The effect of race on coronary bypass operative mortality  by Bridges, Charles R et al.
Cardiac Surgery
The Effect of Race on
Coronary Bypass Operative Mortality
Charles R. Bridges, MD, SCD, FACC,* Fred H. Edwards, MD, FACC,†
Eric D. Peterson, MD, MPH, FACC,‡ Laura P. Coombs, PHD§
Philadelphia, Pennsylvania; Jacksonville, Florida; Durham, North Carolina
OBJECTIVES The study was done to determine whether race is an independent predictor of operative
mortality after coronary artery bypass graft (CABG) surgery.
BACKGROUND Blacks are less frequently referred for cardiac catheterization and CABG than are whites. Few
reports have investigated the relative fate of patients who undergo CABG as a function of
race.
METHODS The Society of Thoracic Surgeons National Database was used to retrospectively review
25,850 black and 555,939 white patients who underwent CABG-alone from 1994 through
1997. A multivariate logistic regression model was developed to determine whether race
affected risk-adjusted operative mortality.
RESULTS Operative mortality was 3.83% for blacks versus 3.14% for whites (unadjusted black/white
odds ratio [OR] 1.23 [1.15–1.31]). Blacks were younger, more likely female, hypertensive,
diabetic and in heart failure. Nonetheless, the influence of these and other preoperative risk
factors on procedural mortality was quite similar in black and white patients. After controlling
for all risk factors, race remained a significant independent predictor of mortality in the
multivariate logistic model (adjusted black/white OR 1.29 [1.21, 1.38]). Proportionately,
these differences were greatest among lower-risk patients. The race-by-gender interaction was
significant (p , 0.05). The unadjusted mortality for black men, 3.30% and white men, 2.64%
differed significantly (p , 0.05), whereas for women there was no difference (black, 4.49%;
white 4.41%).
CONCLUSIONS Black race is an independent predictor of operative mortality after CABG except for very
high-risk patients. The difference in mortality is greatest for male patients and, though
statistically significant, is small in absolute terms. Therefore, patients should be referred for
CABG based on clinical characteristics irrespective of race. (J Am Coll Cardiol 2000;36:
1870–6) © 2000 by the American College of Cardiology
Various studies have shown that black patients are less
frequently referred for cardiac catheterization (1–5), percu-
taneous transluminal coronary angioplasty (PTCA) (1,2,4–
13) and coronary artery bypass graft surgery (CABG)
(1,2,4–8,10–14) than white patients. In general, these
differences cannot be accounted for on the basis of disease
severity (3,4,7–9,13,14) or the availability of health insur-
ance or socioeconomic status (2–4,6,8,13). Racial bias on
the part of physicians has been implicated as one possible
contributing factor (3). It is also worth noting that this racial
disparity in the use of revascularization procedures has been
associated with lower long-term survival among blacks (7).
These observations galvanize the view that efforts need to be
made to encourage wider use of revascularization procedures
in blacks to address this apparent underutilization. As part
of this effort, patients and their physicians should under-
stand the unique risks and benefits of these procedures
among black patients. However, to date, there has been
relatively limited information on the influence of race on the
acute outcomes of bypass surgery.
The Society of Thoracic Surgeons National Cardiac
Surgery Database, commonly called the STS Database,
provides a unique opportunity to address this important
question with statistical rigor and power. This report will
analyze the national CABG surgical results taken from
patients entered into the STS Database from 1994 through
1997. We sought to answer the following questions: Do
blacks have poorer acute outcomes following CABG com-
pared with whites? Are the important preoperative predic-
tors of outcomes similar in black and white patients? Do
blacks present later or more emergently for bypass surgery
than whites? Is race a significant independent predictor of
CABG operative mortality after accounting for other
known risk factors?
MATERIALS AND METHODS
The population is taken from patients who underwent
CABG alone without concomitant procedures, registered in
the STS Database from 1994 through 1997. The data
represent 47 states (Idaho, Vermont and Maine are not
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represented), and 5 Canadian provinces (Alberta, Manitoba,
Nova Scotia, New Brunswick and Quebec). To be included
in the study, patients had to be at least 20 years old and
recorded as either black or white on their data collection
form. The final analysis included 581,789 patients, of whom
25,850 were black and 555,939 were white.
Patient characteristics were tabulated by race (Table 1),
and the differences in proportions for categorical variables
were tested using chi-square tests; mean differences for
continuous variables were tested using t tests. Overall rates
of operative mortality (defined as “mortality occurring at any
time in the hospital during the same admission or within 30
days of surgery”), procedural complications and length of
stay for blacks and whites were also examined (Table 2).
Complications included the following: central neurologic
deficit persisting more than 72 h; pulmonary insufficiency
requiring ventilatory support; operative re-intervention for
bleeding; acute postoperative renal insufficiency; and deep
sternal infection involving muscle, bone, and/or mediasti-
num. Univariate operative mortality rates by risk factor for
blacks and whites were also compared (Table 3).
Next, a logistic regression model of CABG operative
mortality was developed using stepwise logistic regression
and including all the risk factors as the set of possible
predictors. Given the large sample size, independent pre-
dictors of mortality were retained in the model if their
significance was ,0.001. Race was then added to the model
to determine whether it had any predictive ability after
adjusting for the risk factors already in the model.
Interactions between race and other risk factors were
examined in two ways. First, interactions between race and
risk factors of interest (e.g., gender, diabetes, hypertension,
cerebrovascular [CVA], age, reoperation, shock, obesity)
were added to the logistic model to determine their signif-
icance. Alternatively, the risk factors from the model devel-
oped on all patients were used to model white patients and
black patients separately. A comparison of the odds ratio
(OR) for the two groups made any differences between
blacks and whites more apparent (Table 4).
Finally, the relationship between preoperative risk and
race was examined more closely. Specifically, black patients
and white patients were classified into decile groupings
based on their preoperative risk scores (obtained from the
multivariable model with race excluded). Observed mortal-
ity rates for blacks and whites in each risk group were then
calculated. Graphs of observed mortality by risk decile
grouping are presented in Figure 1. Graphs of the black/
white ORs using the same decile groupings are presented in
Figure 2. To determine whether the difference in mortality
rate between blacks and whites was constant across risk
score, the race-by-risk interaction was tested for significance
using logistic regression.
Abbreviations and Acronyms
BSA 5 body surface area
B/W 5 black/white
CABG 5 coronary artery bypass graft
CAD 5 coronary artery disease
CVA 5 cerebrovascular accident
CVD 5 cerebrovascular disease
COPD 5 chronic obstructive pulmonary disease
IABP 5 intraaortic balloon pump
LVH 5 left ventricular hypertrophy
MI 5 myocardial infarction
NYHA 5 New York Heart Association
OR 5 odds ratio
PVD 5 peripheral vascular disease
Table 1. Patient Characteristics by Race
Characteristic*
Black
(n 5 25,850)
White
(n 5 555,939)
p
Value
Age 61.5 6 10.7 64.8 6 10.5 ,0.01
Gender—Male 55.55 72.07 ,0.01
BSA 1.94 6 0.23 1.95 6 0.23 ,0.01
Smoking history 58.50 58.81 0.33
Family history 39.10 47.77 ,0.01
Diabetes 43.78 27.82 ,0.01
Morbid obesity 15.39 11.37 ,0.01
Hypercholesterolemia 47.13 50.66 ,0.01
Renal failure 6.36 2.25 ,0.01
Dialysis 2.36 0.46 ,0.01
Hypertension 80.48 62.38 ,0.01
Cerebrovascular accident 8.19 6.04 ,0.01
Arrhythmia 9.99 13.14 ,0.01
COPD 12.26 15.06 ,0.01
PVD 16.16 13.32 ,0.01
Cerebrovascular disease 8.27 9.09 ,0.01
PTCA within 6 h 1.93 2.25 ,0.01
Previous MI 51.14 49.73 ,0.01
Unstable angina 56.12 55.20 ,0.01
Congestive heart failure 17.43 12.36 ,0.01
Cardiogenic shock 5.30 6.32 ,0.01
Resuscitation 1.24 1.29 0.049
NYHA class ,0.01
Missing 28.87 24.14
I 10.29 9.26
II 10.24 11.15
III 28.70 31.90
IV 21.90 23.56
Previous operations ,0.01
Missing 0.92 0.37
0 94.21 91.22
1 4.62 7.84
21 0.24 0.56
Status ,0.01
Missing 1.54 0.82
Elective 63.18 62.13
Urgent 27.90 28.51
Emergent 6.60 7.67
Salvage 0.79 0.87
Number of diseased vessels ,0.01
Missing 4.15 2.41
1 5.11 5.17
2 21.30 22.40
3 69.44 70.03
Left-main disease 18.71 20.14 ,0.01
Preoperative IABP 5.72 6.90 ,0.01
Ejection fraction 48.2 6 14.2 50.7 6 14.0 ,0.01
*Continuous variables are presented as means 6 SD; categorical data are presented as
percentage of patients.
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RESULTS
General demographics. A comparison of clinical preoper-
ative risk factors for blacks and whites (Table 1) shows
significant differences between the two groups. Because of
the large number of patients in this analysis, nearly all
univariate risk factors differ significantly as a function of race
(p , 0.01). Several differences are striking, however. In
general, black CABG patients were more likely to be female
than were white patients (44.4% vs. 27.9%, p , 0.001).
Black patients were also younger, having an average age of
61.5 years versus 64.8 years for whites. Black patients were
more likely to have hypertension (80.5% vs. 62.4%), diabetes
(43.8% vs. 27.8%), morbid obesity (15.4% vs. 11.4%) and
renal disease (6.4% vs. 2.3%) than whites. However, we did
not find strong evidence that blacks were referred for bypass
later or in more emergent states than whites. Specifically,
blacks were less likely to have their cases done under urgent,
emergent or salvage conditions and had less New York
Heart Association (NYHA) class IV symptoms at the time
of bypass. Additionally, black patients did not appear to
have more severe coronary disease anatomy or markedly
worse left ventricular function (Table 1).
Operative outcomes by race. Table 2 provides the acute
outcomes of bypass surgery for black patients and white
Table 2. CABG Mortality, Complications, and Length of Stay
by Race
Outcome Black White
Unadjusted
OR*
Operative mortality (%) 3.83 3.14 1.23 (1.15, 1.31)
Complications
Stroke—Permanent (%) 2.19 1.62 1.36 (1.25, 1.48)
Prolonged ventilation (%) 7.94 6.05 1.34 (1.28, 1.40)
Reoperation for bleeding
(%)
2.53 2.29 1.10 (1.02, 1.20)
Renal failure (%) 4.32 3.07 1.42 (1.34, 1.51)
Infection-sternum-deep
(%)
.77 .64 1.22 (1.05, 1.40)
Length of stay
(Mean 6 SD)
11.02 6 10.24 9.56 6 8.0
Postop length of stay
(Mean 6 SD)
8.09 6 9.1 7.23 6 7.1
*Black vs. white unadjusted OR with 95% confidence interval.
Table 3. Comparison of Operative Mortality for Specific Subpopulations
Black
(n)
Black Mortality
Rate
White
(n)
White Mortality
Rate
Odds Ratio*
(95% CI)
Age:
.65 years 10,915 5.45 309,035 4.27 1.29 (1.19, 1.41)
,65 years 14,935 2.64 246,904 1.72 1.55 (1.40, 1.72)
Gender:
Male 14,359 3.30 400,654 2.64 1.26 (1.15, 1.38)
Female 11,475 4.49 155,124 4.41 1.02 (0.93, 1.12)
Diabetes:
Yes 11,318 4.57 154,637 3.98 1.16 (1.05, 1.27)
No 14,532 3.25 401,302 2.81 1.16 (1.06, 1.28)
Hypertension:
Yes 20,805 4.12 346,782 3.46 1.20 (1.12, 1.29)
No 5,054 2.62 209,157 2.60 1.01 (0.84, 1.20)
EF:
..50 11,079 3.12 275,670 2.12 1.49 (1.33, 1.66)
,.50 14,771 4.35 280,269 4.13 1.06 (0.97, 1.14)
Renal Failure:
Yes 1,643 7.61 12,505 10.51 0.70 (0.58, 0.85)
No 24,207 3.57 543,434 2.97 1.21 (1.13, 1.30)
*Black vs. white OR with 95% confidence interval.
Table 4. Multivariate Logistic Regression Model by Race
Risk Factor*
Black Odds Ratio
(95% CI)
White Odds Ratio
(95% CI)
Reoperation 2.37 (1.92, 2.94) 2.72 (2.61, 2.83)
Age (10 yrs) 1.42 (1.33, 1.53) 1.54 (1.51, 1.57)
Ejection fraction (10%) 0.97 (0.92, 1.02) 0.87 (0.86, 0.88)
Preop IABP 1.48 (1.18, 1.85) 1.66 (1.59, 1.75)
PVD 1.33 (1.14, 1.56) 1.50 (1.44, 1.56)
Renal failure 1.60 (1.24, 2.07) 1.95 (1.82, 2.10)
Resuscitation 1.92 (1.33, 2.75) 2.07 (1.91, 2.23)
COPD 1.17 (0.97, 1.40) 1.39 (1.34, 1.45)
Shock 1.78 (1.33, 2.37) 1.73 (1.62, 1.85)
Female 1.07 (0.92, 1.24) 1.40 (1.34, 1.46)
Emergent/salvage 1.98 (1.53, 2.57) 1.55 (1.46, 1.65)
Diabetes 1.27 (1.11, 1.45) 1.27 (1.23, 1.32)
Arrhythmia 1.13 (0.93, 1.37) 1.29 (1.24, 1.34)
MI 1.25 (1.09, 1.44) 1.23 (1.19, 1.27)
Left main 1.08 (0.92, 1.26) 1.23 (1.19, 1.28)
BSA 0.44 (0.31, 0.63) 0.62 (0.57, 0.68)
Hypercholesterolemia 0.79 (0.69, 0.91) 0.84 (0.81, 0.87)
PTCA ,6 h 1.30 (0.92, 1.85) 1.55 (1.43, 1.67)
NYHA class IV 1.11 (0.96, 1.29) 1.21 (1.17, 1.25)
Diseased vessels 5 3 1.39 (1.18, 1.62) 1.20 (1.16, 1.25)
Morbid obesity 1.25 (1.03, 1.51) 1.27 (1.21, 1.34)
CVA 1.61 (1.29, 2.00) 1.26 (1.19, 1.33)
Dialysis 1.30 (0.88, 1.93) 1.77 (1.53, 2.05)
Hypertension 1.43 (1.18, 1.73) 1.12 (1.08, 1.16)
Immunosuppressants 1.41 (0.84, 2.35) 1.39 (1.24, 1.54)
CVD 1.07 (0.85, 1.34) 1.15 (1.09, 1.21)
Family history CAD 0.87 (0.76, 1.01) 0.93 (0.90, 0.96)
*Risk factors are sorted in order of their contribution to the model containing all
patients as determined by the value of the Wald chi-square statistic.
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patients. The operative mortality was 3.83% for blacks and
3.14% for whites, p , 0.001, unadjusted black/white (B/W)
OR 1.23 [1.15–1.310]. Similarly, blacks had higher rates of
postoperative complications, including stroke (B/W OR
1.36 [1.25, 1.48]), reoperation for bleeding (B/W OR 1.10
[1.02–1.20], prolonged ventilation (B/W OR 1.34 [1.28,
1.40]), renal failure (B/W OR 1.42 [1.34, 1.51]) and deep
sternal wound infection (B/W OR 1.22 [1.05, 1.40]).
Postoperative length of stays were also slightly longer for
black patients (Table 2).
Table 3 shows the operative mortality for blacks and
whites among important clinical subsets. The operative
mortality was higher for blacks in most risk categories. For
one important risk factor, however, blacks had a signifi-
cantly lower operative mortality. The operative mortality for
blacks with renal failure (7.6%) was lower than the operative
mortality for whites with renal failure (10.5%), p 5 0.0003.
Risk model comparisons. Using stepwise logistic regres-
sion, we identified 27 preoperative characteristics associated
with operative mortality. A summary of the results of the
logistic regression model appears in Table 4. The risk
factors in Table 4 have been arranged according to their
Figure 1. Race by risk interaction. Observed operative mortality is shown for black and white patients as a function of the preoperative risk group.
Figure 2. Comparison of the black:white operative mortality OR for different preoperative risk groups.
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contribution to the predictive power of the overall model (as
assessed by the value of the Wald chi-square statistic). Thus,
age, reoperation, the need for preoperative intraaortic bal-
loon pump (IABP) and ejection fraction emerge as the
strong multivariate predictors of operative mortality. The
overall ability of this model to discriminate patients who
would live from those who would die was excellent (area
under the ROC curve or C-statistic 5 0.78).
To test whether race was an important independent
predictor of operative mortality, we added race to our overall
multivariable model. After controlling for the 27 other
known risk factors, blacks had 29% higher operative mor-
tality risk compared with whites (adjusted B/W OR 1.29
[1.21, 1.38]). Thus, patient race is an independent risk
factor for bypass mortality even after accounting for other
differences in patient clinical profiles.
While race is an independent risk factor for procedural
outcomes, other known preoperative mortality risk factors
among blacks and whites were strikingly similar (Table 4).
Specifically, when the multivariable model was applied in
black patient and white patient subsets separately, the
directionality and magnitude of the ORs for these risk
factors were quite similar in blacks and whites (Table 4). We
also more formally tested for race by risk factor interactions
in the overall patient population. Of the interactions exam-
ined, only race by gender was significant (p , 0.05),
indicating that the difference in mortality between blacks
and whites was more pronounced for men than for women.
In fact, there was no significant difference in unadjusted
mortality between black and white women (4.49% vs.
4.41%; p 5 NS).
Finally, the relationship between race and overall mortal-
ity risk was examined. Specifically, black patients and white
patients were grouped into equal-sized deciles by their
calculated operative mortality risk (based on the multivari-
able model). As demonstrated in Figure 1, blacks had
slightly higher observed mortality across all risk deciles.
When examined as risk ratios (Fig. 2), however, it becomes
clear that B/W mortality differences are greatest among
those patients at lowest predicted operative risk. For example,
in Decile 1 (lowest-risk patients), the B/W OR for observed
mortality was 1.83, whereas among those in Decile 10 (highest
risk) this observed B/W mortality risk was only 1.03. In fact, a
formal test of race by risk interaction was significant (p ,
0.05), indicating that the difference in mortality rates for blacks
and whites is not the same across risk groups.
DISCUSSION
We used the Society of Thoracic Surgery National Database
to study the effect of race on CABG operative mortality for
555,939 white and 25,850 black patients who underwent
CABG from 1994 through 1997. Our analysis has indicated
that blacks have a higher operative mortality after CABG
than white patients with similar risk profiles. This increase
in the relative risk of CABG among blacks, however, is
modest in absolute terms (3.83% vs. 3.14%) and is concen-
trated among males and those with low preoperative risk
profiles. In fact, black women and white women have equal
unadjusted mortality risk, as do patients with high operative
risk.
Comparison with previous studies. Prior to the present
study, there have been relatively few published investiga-
tions of the effect of race on CABG operative mortality or
postoperative long-term survival (15–21). Gray et al. (21)
reviewed the records of 3,113 white and 115 black patients
who underwent CABG at Cedars-Sinai Medical Center
from 1984 through mid-1994. The operative mortality was
5.5% for blacks and 4.6% for whites, p 5 0.48. Although
there was no significant difference in operative mortality in
this study, a multivariate analysis was performed only for
long-term survival (21). Higgins et al. (19) analyzed the
results of 2,282 white and 494 black patients undergoing
CABG from 1990 to 1996 at Henry Ford Hospital in
Detroit. The overall operative mortality was 5.5% for black
patients and 2.5% for white patients (p , 0.003). However,
using multivariate logistic regression, race was not a signif-
icant predictor of mortality (19).
Maynard et al. (18) using the Coronary Artery Surgery
Study (CASS) database found no statistically significant
difference in the five-year survival of patients treated surgi-
cally as a function of race. Taylor et al. (20) also using the
CASS database, examined the records of 22,714 white and
571 black patients who underwent angiography between
1974 and 1979. Long-term (.10-year follow-up) survival
for surgically treated patients was significantly lower for
black patients than for white patients, with black race
emerging as a significant adverse predictor of long-term
survival in a multivariate Cox proportional hazards model.
The search for alternative risk factors. The reasons for
the higher operative mortality observed in black patients in
this study are not clear. It is difficult to understand how race
per se should have a significant impact on operative mor-
tality once all known risk factors have been considered in a
multivariate model. Our results suggest several possible
hypotheses. First, we found that the average age of the black
CABG patients in our population (61.5 years) is signifi-
cantly lower than the average age of the white patients (64.8
years; p 5 0.0001). Yet if a multivariate analysis is per-
formed excluding race as a variable, the predicted mortality
for black patients is 3.12%, whereas the predicted mortality
for whites is 3.14%. Despite younger age, black patients
have similar predicted mortality independent of race. Thus,
black patients were generally younger and slightly sicker for
their age than were white patients. Therefore, race in this
study may be a marker for patients with more rapid rate of
progression of coronary artery disease (CAD), in particular,
and vascular disease, in general.
This finding of potentially more aggressive atherosclero-
sis in black patients is also consistent with the observed
higher rates of cerebrovascular disease, hypertension, and
renal disease in blacks relative to whites. The factors that
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correlate with vascular disease progression, such as eleva-
tions in C-reactive protein, are likely to be more prevalent in
these patients (22). The associated inflammatory milieu is
likely to exacerbate end organ function to a greater extent
after cardiopulmonary bypass and to increase the risk of
cardiac, neurological, pulmonary and renal complications
after surgery, as we observed (23) (Table 2). These and other
serum factors may also be important in determining CABG
operative mortality, considering that the removal of inflam-
matory mediators using conventional and modified ultrafil-
tration has recently been shown to improve pulmonary,
hemostatic and cardiac function after cardiac surgery in
adults (24). Endothelial dysfunction has also been raised
(25) as a risk factor for hypertension, and perhaps it could
lead to complications in patients after CABG.
Blacks, in the absence of angiographic evidence of CAD,
have a significant reduction in endothelium-independent
coronary flow reserve compared with whites (25). Addition-
ally, the depressed coronary vascular relaxation in response
to both acetylcholine and adenosine in black patients has
been associated with the higher prevalence of left ventricular
hypertrophy (LVH) seen in blacks (26). For a given degree
of hypertension, black patients are more likely to have
significant LVH (27). In this analysis, although LVH was
not specifically studied, we did, however, note that racial
differences in operative mortality appeared to be limited to
those patients with hypertension (Table 3). Specifically,
although hypertensive blacks had significantly higher oper-
ative mortality than whites, race was not a significant
predictor of surgical outcome among normotensive patients.
The LVH may be more prevalent in the black patients
studied with hypertension, perhaps increasing the incidence
of postoperative arrhythmias or compromising myocardial
protection during cardiopulmonary bypass.
Finally, as previous researchers have indicated, the study
of racial differences in care and outcome is complex (28).
Dichotomous variables based on skin tone do not capture
the ethnic and biological diversity inherent among humans.
Additionally, race is often a surrogate marker for underlying
socio-economic, educational, behavioral and cultural differ-
ences. Unfortunately, these factors were not collected within
our study, but the potential influence of these and other
nonbiologic factors on both the short- and long-term
outcomes of CABG should be the focus of future studies.
Conclusions. In summary, the finding that race is an
independent predictor of operative mortality after CABG
should prompt a more careful search for additional risk
factors for CABG operative mortality. The unexpected
finding of a significant race/gender interaction is important.
In the general population, female gender is an independent
predictor of operative mortality after CABG (29,30) (Table
4). Thus, further analysis of the differential effects of race
and gender on outcome, as functions of gender and race,
respectively, is required. Although the operative mortality
after CABG is significantly higher for blacks than for
whites, the differences are relatively small in absolute terms.
Therefore, patients should continue to be referred for
CABG based on established clinical criteria, independent of
race.
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